| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| NewAmsterdam Pharma Co N.V. | Chief Strategy and Business Officer | Ordinary Shares | 15.1K | $386K | $25.54 | Jan 7, 2025 | Direct |
| NewAmsterdam Pharma Co N.V. | Chief Strategy and Business Officer | Option (right to buy) | 30K | May 1, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| NAMS | NewAmsterdam Pharma Co N.V. | May 1, 2025 | 1 | $0 | 4 | May 2, 2025 | Chief Strategy and Business Officer |
| NAMS | NewAmsterdam Pharma Co N.V. | Jan 7, 2025 | 1 | $0 | 4 | Jan 7, 2025 | Chief Business Officer |
| NAMS | NewAmsterdam Pharma Co N.V. | Jan 2, 2025 | 1 | $0 | 4 | Jan 6, 2025 | Chief Business Officer |
| NAMS | NewAmsterdam Pharma Co N.V. | Sep 26, 2024 | 1 | $17.3K | 4 | Sep 30, 2024 | Chief Business Officer |
| NAMS | NewAmsterdam Pharma Co N.V. | Apr 1, 2024 | 1 | $0 | 4 | Apr 2, 2024 | Chief Business Officer |
| NAMS | NewAmsterdam Pharma Co N.V. | Dec 29, 2023 | 0 | $0 | 3 | Dec 29, 2023 | Director |